Pleiotropic antifibrotic actions of aspirin-triggered resolvin D1 in the lungs

INTRODUCTION: Pulmonary fibrosis is a destructive, progressive disease that dramatically reduces life quality of patients, ultimately leading to death. Therapeutic regimens for pulmonary fibrosis have shown limited benefits, hence justifying the efforts to evaluate the outcome of alternative treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Guilherme, Rafael F., Silva, José Bruno N.F., Waclawiack, Ingrid, Fraga-Junior, Vanderlei S., Nogueira, Thaís O., Pecli, Cyntia, Araújo-Silva, Carlla A., Magalhães, Nathalia S., Lemos, Felipe S., Bulant, Carlos A., Blanco, Pablo J., Serra, Rafaela, Svensjö, Erik, Scharfstein, Júlio, Moraes, João A., Canetti, Claudio, Benjamim, Claudia F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030054/
https://www.ncbi.nlm.nih.gov/pubmed/36960058
http://dx.doi.org/10.3389/fimmu.2023.886601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030054/
https://www.ncbi.nlm.nih.gov/pubmed/36960058
http://dx.doi.org/10.3389/fimmu.2023.886601

Ejemplares similares